409 related articles for article (PubMed ID: 9780005)
1. Prolonged vs transient roles for early cell cycle signaling components.
Rose DW; Xiao S; Pillay TS; Kolch W; Olefsky JM
Oncogene; 1998 Aug; 17(7):889-99. PubMed ID: 9780005
[TBL] [Abstract][Full Text] [Related]
2. Formation of distinct signalling complexes involving phosphatidylinositol 3-kinase activity with stimulation of epidermal growth factor or insulin-like growth factor-I in human skin fibroblasts.
Takahashi Y; Akanuma Y; Yazaki Y; Kadowaki T
J Cell Physiol; 1999 Jan; 178(1):69-75. PubMed ID: 9886492
[TBL] [Abstract][Full Text] [Related]
3. IGF-I receptor protection from apoptosis in cells lacking the IRS proteins.
Dews M; Nishimoto I; Baserga R
Recept Signal Transduct; 1997; 7(4):231-40. PubMed ID: 9633824
[TBL] [Abstract][Full Text] [Related]
4. Requirement of phospholipase C gamma, the tyrosine phosphatase Syp and the adaptor proteins Shc and Nck for PDGF-induced DNA synthesis: evidence for the existence of Ras-dependent and Ras-independent pathways.
Roche S; McGlade J; Jones M; Gish GD; Pawson T; Courtneidge SA
EMBO J; 1996 Sep; 15(18):4940-8. PubMed ID: 8890167
[TBL] [Abstract][Full Text] [Related]
5. Expression of a catalytically inert Syp blocks activation of MAP kinase pathway downstream of p21ras.
Sawada T; Milarski KL; Saltiel AR
Biochem Biophys Res Commun; 1995 Sep; 214(2):737-43. PubMed ID: 7677789
[TBL] [Abstract][Full Text] [Related]
6. Role of PI 3-kinase and SH-PTP2 in insulin action.
Kasuga M
Diabet Med; 1996 Sep; 13(9 Suppl 6):S87-9. PubMed ID: 8894489
[TBL] [Abstract][Full Text] [Related]
7. Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells.
Batty IH; Fleming IN; Downes CP
Biochem J; 2004 May; 379(Pt 3):641-51. PubMed ID: 14769130
[TBL] [Abstract][Full Text] [Related]
8. Dual regulation of upstream binding factor 1 levels by IRS-1 and ERKs in IGF-1-receptor signaling.
Sun H; Tu X; Liu M; Baserga R
J Cell Physiol; 2007 Sep; 212(3):780-6. PubMed ID: 17443674
[TBL] [Abstract][Full Text] [Related]
9. Association of insulin receptor substrate 3 with SH2 domain-containing proteins in rat adipocytes.
Ross SA; Lienhard GE; Lavan BE
Biochem Biophys Res Commun; 1998 Jun; 247(2):487-92. PubMed ID: 9642156
[TBL] [Abstract][Full Text] [Related]
10. The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor.
Easton JB; Royer AR; Middlemas DS
J Neurochem; 2006 May; 97(3):834-45. PubMed ID: 16573649
[TBL] [Abstract][Full Text] [Related]
11. Extracellular matrix induced by TGFbeta impairs insulin signal transduction in 3T3-L1 preadipose cells.
Gagnon AM; Chabot J; Pardasani D; Sorisky A
J Cell Physiol; 1998 Jun; 175(3):370-8. PubMed ID: 9572482
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of EGFR-mediated phosphoinositide-3-OH kinase (PI3-K) signaling and glioblastoma phenotype by signal-regulatory proteins (SIRPs).
Wu CJ; Chen Z; Ullrich A; Greene MI; O'Rourke DM
Oncogene; 2000 Aug; 19(35):3999-4010. PubMed ID: 10962556
[TBL] [Abstract][Full Text] [Related]
13. Adapter protein with a pleckstrin homology (PH) and an Src homology 2 (SH2) domain (APS) and SH2-B enhance insulin-receptor autophosphorylation, extracellular-signal-regulated kinase and phosphoinositide 3-kinase-dependent signalling.
Ahmed Z; Pillay TS
Biochem J; 2003 Apr; 371(Pt 2):405-12. PubMed ID: 12521378
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1.
Tamemoto H; Kadowaki T; Tobe K; Yagi T; Sakura H; Hayakawa T; Terauchi Y; Ueki K; Kaburagi Y; Satoh S
Nature; 1994 Nov; 372(6502):182-6. PubMed ID: 7969452
[TBL] [Abstract][Full Text] [Related]
15. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene.
Araki E; Lipes MA; Patti ME; Brüning JC; Haag B; Johnson RS; Kahn CR
Nature; 1994 Nov; 372(6502):186-90. PubMed ID: 7526222
[TBL] [Abstract][Full Text] [Related]
16. Insulin and IGF-I signaling through the insulin receptor substrate 1.
Keller SR; Lamphere L; Lavan BE; Kuhné MR; Lienhard GE
Mol Reprod Dev; 1993 Aug; 35(4):346-51; discussion 351-2. PubMed ID: 8398112
[TBL] [Abstract][Full Text] [Related]
17. Functional insulin and insulin-like growth factor-1 receptors are preferentially expressed in multiple myeloma cell lines as compared to B-lymphoblastoid cell lines.
Freund GG; Kulas DT; Way BA; Mooney RA
Cancer Res; 1994 Jun; 54(12):3179-85. PubMed ID: 8205537
[TBL] [Abstract][Full Text] [Related]
18. Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes.
Valverde AM; Lorenzo M; Pons S; White MF; Benito M
Mol Endocrinol; 1998 May; 12(5):688-97. PubMed ID: 9605931
[TBL] [Abstract][Full Text] [Related]
19. Functional interactions between isolated SH2 domains and insulin/Ras signaling pathways of Xenopus oocytes: opposite effects of the carboxy- and amino-terminal SH2 domains of p85 PI 3-kinase.
Aroca P; Mahadevan D; Santos E
Oncogene; 1996 Nov; 13(9):1839-46. PubMed ID: 8934529
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways.
Sasaoka T; Ishiki M; Sawa T; Ishihara H; Takata Y; Imamura T; Usui I; Olefsky JM; Kobayashi M
Endocrinology; 1996 Oct; 137(10):4427-34. PubMed ID: 8828504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
